PET/CT bests biopsy in diagnosing lymphoma bone marrow involvement

05/17/2013 | MolecularImaging.net

A study published in The Journal of Nuclear Medicine said 18F-FDG-PET/CT is better than the standard bone marrow biopsy in detecting bone marrow involvement in diffuse large B-cell lymphoma. PET/CT identified bone marrow involvement in 32 patients, while biopsy detected bone malignancy in eight patients. PET/CT also showed better performance in terms of sensitivity, predictive value and negative predictive value.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC